These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29394636)

  • 1. [An Enhanced Multimodality Treatment Strategy in Pancreatic Ductal Carcinoma Requiring Heminephrectomy for Radical Resection - A Case Report].
    Kitagawa A; Iwagami Y; Eguchi H; Yamada D; Asaoka T; Noda T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1367-1369. PubMed ID: 29394636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
    Loehrer AP; Ferrone CR
    Dig Surg; 2016; 33(4):343-50. PubMed ID: 27216011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Resected Case of UR-LA Pancreatic Tail Cancer with Aortic Invasion after Chemoradiotherapy].
    Fujimura Y; Tabata M; Sakamoto T; Maeda K; Ohsawa I; Kato K; Iwata M; Sanda T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):151-153. PubMed ID: 29362338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer.
    Eguchi H; Nagano H; Tanemura M; Takeda Y; Marubashi S; Kobayashi S; Kawamoto K; Wada H; Hama N; Akita H; Mori M; Doki Y
    Hepatogastroenterology; 2013 Jun; 60(124):904-11. PubMed ID: 23321032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
    Akita H; Takahashi H; Ohigashi H; Tomokuni A; Kobayashi S; Sugimura K; Miyoshi N; Moon JH; Yasui M; Omori T; Miyata H; Ohue M; Fujiwara Y; Yano M; Ishikawa O; Sakon M
    Eur J Surg Oncol; 2017 Jun; 43(6):1061-1067. PubMed ID: 28389044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [R0 Resection by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Down-Staging by FOLFIRINOX Therapy in a Case of Pancreas Cancer--Report of a Case].
    Makino H; Kametaka H; Fukada T; Seike K; Koyama T; Hasegawa A
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1644-6. PubMed ID: 26805124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of total remnant pancreatectomy for ductal carcinoma after distal pancreatectomy for invasive intraductal papillary mucinous carcinoma].
    Okubo K; Hama N; Kobayashi S; Eguchi H; Akita H; Wada H; Kawamoto K; Marubashi S; Tanemura M; Umeshita K; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2140-2. PubMed ID: 23268003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.
    Fujii T; Satoi S; Yamada S; Murotani K; Yanagimoto H; Takami H; Yamamoto T; Kanda M; Yamaki S; Hirooka S; Kon M; Kodera Y
    J Gastroenterol; 2017 Jan; 52(1):81-93. PubMed ID: 27169844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.
    Kalimuthu SN; Serra S; Dhani N; Chetty R
    J Clin Pathol; 2016 Jun; 69(6):463-71. PubMed ID: 26915370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
    Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of a patient who underwent resection of the remnant pancreatic cancer following a distal pancreatectomy for invasive ductal carcinoma].
    Sui K; Niguma T; Yamada M; Kojima T; Mimura T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2163-5. PubMed ID: 25731457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
    Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
    Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resection of Pancreatic Metastasis from Renal Cell Carcinoma 21 Years after Nephrectomy].
    Miura T; Nakamura N; Ogawa K; Watanabe Y; Yonekura K; Sanada T; Kuwabara H; Goseki N
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2187-2189. PubMed ID: 28133264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
    Kang CM; Hwang HK; Choi SH; Lee WJ
    Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer].
    Miyamoto T; Inoue M; Tanemura M; Yamaguchi M; Irei T; Tamaru K; Seo S; Misumi T; Shimizu W; Suzuki T; Onoe T; Sudo T; Shimizu Y; Hinoi T; Tashiro H
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):88-90. PubMed ID: 29362317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.
    Cesaretti M; Abdel-Rehim M; Barbier L; Dokmak S; Hammel P; Sauvanet A
    J Visc Surg; 2016 Jun; 153(3):173-81. PubMed ID: 26775202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 5-year survival case of locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemoradiation therapy].
    Iseki M; Motoi F; Mizuma M; Hayashi H; Nakagawa K; Okada T; Otsuka H; Ottomo S; Sakata N; Fukase K; Yoshida H; Onogawa T; Naito T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1948-50. PubMed ID: 23267939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.